Literature DB >> 6890640

Motor abilities after frontal leukotomy.

D F Benson, D T Stuss.   

Abstract

The effect of bilateral frontal leukotomy on motor function was evaluated by neurologic examination, tests of praxis, and appropriate neuropsychologic tests administered to five groups of subjects. Postleukotomy schizophrenic patients were subdivided into three degrees of recovery. Two nonleukotomized groups served as controls for effects of schizophrenia, age, and education. The results indicate that the size of the bifrontal damage was not significant in the response to the motor tests, whereas the severity of schizophrenia clearly affected results. As tested, bilateral orbitofrontal white matter lesions did not disturb motor competency.

Entities:  

Mesh:

Year:  1982        PMID: 6890640     DOI: 10.1212/wnl.32.12.1353

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Cranial MR imaging of sequelae of prefrontal lobotomy.

Authors:  A Uchino; A Kato; T Yuzuriha; Y Takashima; S Kudo
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Frontal lobe disinhibition in attention deficit disorder.

Authors:  G J Chelune; W Ferguson; R Koon; T O Dickey
Journal:  Child Psychiatry Hum Dev       Date:  1986

3.  Abnormal subjective experiences in schizophrenia: its relationships with neuropsychological disturbances and frontal signs.

Authors:  M J Cuesta; V Peralta; J A Juan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 4.  Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk.

Authors:  A L Wolff; G A O'Driscoll
Journal:  J Psychiatry Neurosci       Date:  1999-09       Impact factor: 6.186

5.  Executive control: balancing stability and flexibility via the duality of evolutionary neuroanatomical trends.

Authors:  Robert M Bilder
Journal:  Dialogues Clin Neurosci       Date:  2012-03       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.